You are here

Reinhard Stauder (AT)

Associate Professor at the Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck, Austria

Reinhard Stauder received his Doctoral Degree in Medicine in 1981 from the University of Innsbruck and in 2006 received a Master's Degree in Health Sciences from the University of Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria. From 1994 – 1996, he was Scientific Member at the Basel Institute for Immunology, Basel, Switzerland.

RS is a specialist in Internal Medicine, a Certified Specialist in Hematology and Oncology and Associate Professor of Medicine at Innsbruck Medical University, Austria. His main clinical and scientific focus lies in Myelodysplastic Syndromes (MDS), in geriatric oncology and in anemia in the elderly. His main goal is the development of individualized treatment algorithms in elderly cancer patients.

At present RS is responsible for the geriatric oncology and MDS program of the Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University. RS is a member of the European Leukemia Net (ELN) and is representative of Austria in the European LeukemiaNet MDS registry (EU-MDS). RS is a member of the board of the Austrian Society for Haematology and Oncology (OEGHO) as well as vice-chairman of the Austrian MDS-Plattform and chairman of the Geriatric Oncology Group of the OEGHO. RS is the National Representative for Austria in the International Society of Geriatric Oncology (SIOG), is editorial board member of “The Journal of Geriatric Oncology” and is founder and chairman of the Austrian association „Aid in elderly cancer patients” (Verein Senioren-Krebshilfe). In addition RS is a member of the Scientific Working Groups on Hematology and Ageing of EHA and ASH.

RS is author of numerous scientific publications including more than 100 publications in peer-reviewed journals. 

November 17, 2018
9:30am to 11:00am Multidisciplinary approach: evaluation and management of toxicities in haem malignancies Room E 102 Simon Mooijaart (NL), Pierre Soubeyran (FR), Marijke Quaghebeur (BE), Nina Neuendorff (DE), Vicki Morrison (US), Reinhard Stauder (AT), Raul Cordoba (SP)